BamSEC and AlphaSense Join Forces
Learn More

Edgewise Therapeutics Inc. – Material Contracts

NASDAQ: EWTX    
Share price (7/8/26): $46.30    
Market cap (7/8/26): $4.982 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 5 pages Amended Outside Director Compensation Policy
12/34/56
EX-10.21
from 10-K 2 pages Material contract
12/34/56
EX-10.1
from 8-K 24 pages Certain Exhibits and Schedules Have Been Omitted in Accordance With Regulation S-K Item 601(a)(5). the Registrant Agrees to Furnish Supplementally a Copy of Any Omitted Exhibit or Schedule to the SEC Upon Its Request, However the Registrant May Request Confidential Treatment of Omitted Items
12/34/56
EX-10.1
from 10-Q 4 pages Outside Director Compensation Policy
12/34/56
EX-10.20
from 10-K 7 pages Robert Blaustein, M.D., PH.D. Re: Employment Offer Dear Dr. Blaustein, This Will Confirm the Terms Under Which Edgewise Therapeutics, Inc. (The “Company”) Has Made You an Offer of Employment
12/34/56
EX-10.2
from S-8 20 pages [***] Portions of This Exhibit Have Been Redacted in Compliance With Regulation S-K Item 601(a)(6) Edgewise Therapeutics, Inc. Notice of Stock Option Grant
12/34/56
EX-10.1
from 8-K 45 pages Edgewise Therapeutics, Inc. 2024 Inducement Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 4 pages Edgewise Therapeutics, Inc. Outside Director Compensation Policy
12/34/56
EX-10.2
from 10-Q 10 pages Edgewise Therapeutics, Inc. ​ 2021 Equity Incentive Plan Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.1
from 10-Q 5 pages ​ Edgewise Therapeutics, Inc. Outside Director Compensation Policy
12/34/56
EX-10.12
from 10-K 6 pages ​ Marc Semigran, M.D. ​ Re: Employment Offer ​ Dear Dr. Semigran, ​ This Will Confirm the Terms Under Which Edgewise Therapeutics, Inc. (The “Company”) Has Made You an Offer of Employment: ​
12/34/56
EX-10.5
from 10-K 21 pages Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.1
from 10-Q 6 pages Joanne Donovan, M.D., PH.D. ​ Re: Employment Offer Dear Dr. Donovan, This Will Confirm the Terms Under Which Edgewise Therapeutics, Inc. (The “Company”) Has Made You an Offer of Employment
12/34/56
EX-10.4
from S-1/A 25 pages Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-1/A 35 pages Edgewise Therapeutics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.14
from S-1 25 pages Lease for Premises Located at Jennie Smoly Caruthers Biotechnology Building University of Colorado Boulder 3415 Colorado Avenue, Boulder, Colorado 80309 by and Between Edgewise Therapeutics, Inc., a Delaware Corporation as Tenant and the Regents of the University of Colorado, a Body Corporate as Landlord
12/34/56
EX-10.13
from S-1 5 pages Edgewise Therapeutics, Inc. Outside Director Compensation Policy
12/34/56
EX-10.12
from S-1 16 pages Edgewise Therapeutics, Inc. Executive Change in Control and Severance Plan and Summary Plan Description
12/34/56
EX-10.11
from S-1 7 pages Edgewise Therapeutics, Inc. Executive Incentive Compensation Plan
12/34/56
EX-10.10
from S-1 5 pages March 3, 2021 John Moore C/O Edgewise Therapeutics, Inc. Re: Confirmatory Employment Letter Dear Mr. Moore
12/34/56